HMGB1 and neoplasm: Therefore, we explored the ability of NO to induce ICD in tumor cells and thus activate dendritic cells (DCs) to generate anti-tumor immune responses by characterizing cell surface exposure to calreticulin (CRT)50 and extracellular release of high-mobility group box 1 (HMGB1)51.